Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Evaluate the Efficacy and Safety of Treatment With "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Associated Asthma

NCT03821077 is registered in ClinicalTrials.gov with Roxall Medicina España S.A as lead sponsor.

NCT NCT03821077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Evaluate the Efficacy and Safety of Treatment With "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Associated Asthma
Lead sponsor
Roxall Medicina España S.A
Phase
Observational
Overall status
Completed
Start date
August 30, 2018
Completion date
September 13, 2021
Enrollment
122 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, allergic, rhinoconjunctivitis